Status:
COMPLETED
Ranibizumab for the Inhibition of Neovascularization in Pterygia
Lead Sponsor:
University of Miami
Conditions:
Pterygium
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The primary purpose of this trial is to evaluate the safety and tolerability of ranibizumab given via subconjunctival injection in patients undergoing pterygium surgery.
Detailed Description
As a secondary objective, this study also aims to establish the tissue concentration of ranibizumab when delivered via subconjunctival injection in patients undergoing pterygium excision and to determ...
Eligibility Criteria
Inclusion
- Subjects will be eligible if the following criteria are met:
- Ability to provide written informed consent and comply with study assessments for the full duration of the study
- Age \> 18 years
- Patient related considerations: All patients of both genders will be considered for enrollment.
- Disease related considerations:
- Patients with pterygia will be considered for enrollment if the pterygium meets standard pterygium excision criteria including encroachment into the visual axis
- severe induced astigmatism
- foreign body sensation unresponsive to medical therapy.
Exclusion
- Subjects who meet any of the following criteria will be excluded from this study:
- Pregnancy (positive pregnancy test)
- Women seeking to become pregnant
- Lactating women
- Prior enrollment in the study
- Prior glaucoma surgery in the region of the pterygium
- Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated
- Participation in another simultaneous medical investigation or trial
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00768963
Start Date
October 1 2008
End Date
January 1 2012
Last Update
July 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bascom Palmer Eye Institute
Miami, Florida, United States, 33136